Article
Interventional psychiatry (Part 2)
- Author:
- Dmitry M. Arbuck, MD
- Ali A. Farooqui, MD
- Rif S. El-Mallakh, MD
Neuromodulation may be an effective option for some patients with difficult-to-treat conditions.
Article
Interventional psychiatry: What are the next steps?
- Author:
- Kathy Vincent, MD
- Megan Good, MD
- Rif S. El-Mallakh, MD
The explosion of interest in interventional psychiatry is highlighted by 2 recent reviews published in Current Psychiatry.
Article
Interventional psychiatry (Part 1)
- Author:
- Dmitry M. Arbuck, MD
- Ali A. Farooqui, MD
- Rif S. El-Mallakh, MD
For some patients, IV medications, blocks, and injections could be effective treatments.
Article
Bipolar disorder: The foundational role of mood stabilizers
- Author:
- Bhumika Shah, MD
- Omar H. Elsayed, MD
- Rif S. El-Mallakh, MD
Bipolar disorder (BD) is a recurrent, life-long psychiatric illness affecting nearly 2% of the world population that is characterized by episodes...
Article
Adaptive changes to antipsychotics: How to avoid the consequences
- Author:
- Ahmad Sleem, MBBCh
- Rif S. El-Mallakh, MD
While our understanding of the mechanisms of psychosis continues to evolve beyond the dopamine hypothesis, the key role...
Article
Serotonin-mediated anxiety: How to recognize and treat it
- Author:
- Sara R. Abell, MD
- Rif S. El-Mallakh, MD
Individuals with anxiety will experience frequent or chronic excessive worry, nervousness, a sense of unease, a feeling of being unfocused, and...
Article
Lithium and kidney disease: Understand the risks
- Author:
- Ziad A. Ali, MD
- Rif S. El-Mallakh, MD
Lithium is one of the most widely used mood stabilizers and is considered a first-line treatment for bipolar disorder because of its proven...
Article
Suvorexant: An option for preventing delirium?
- Author:
- Saba Afshar, MBBS
- Kathryn Marcellus, MD
- Rif S. El-Mallakh, MD
Recent evidence suggests that suvorexant, which is FDA-approved for insomnia, may be useful for preventing delirium.
Article
Posttraumatic stress disorder: From pathophysiology to pharmacology
- Author:
- Bilge Togay, MD
- Rif S. El-Mallakh, MD
PTSD occurs acutely and chronically in the aftermath of severe and potentially life-threatening trauma.
Article
Receptor occupancy and drug response: Understanding the relationship
- Author:
- Rif S. El-Mallakh, MD
Most clinicians do not think about receptor occupancy when they prescribe a medication. Most simply assume that if they use a low dose of a...
Article
Understanding the brexpiprazole therapeutic window: Why more isn’t always better
- Author:
- Anjali Dhanda, MD
- Zachary Sager, MD
- Rif S. El-Mallakh, MD
Dosage windows could be difficult to understand pharmacologically, but for a partial agonist the presumed mechanism could be more evident....
News
How coffee and cigarettes can affect the response to psychopharmacotherapy
- Author:
- Anoop Narahari, MD
- Rif S. El-Mallakh, MD
- Murali K. Kolikonda, MD
- Amandeep Singh Bains, MD
- Steven Lippmann, MD